Franco Cecchi1, Maria Iascone2, Niccolò Maurizi3, Laura Pezzoli2, Irene Binaco1, Elena Biagini4, Maria Laura Fibbi5, Iacopo Olivotto3, Federico Pieruzzi6, Ana Fruntelata7, Lucian Dorobantu7, Claudio Rapezzi4, Paolo Ferrazzi1. 1. Center for Hypertrophic Cardiomyopathy and Valvular Cardiopathies, Monza Hospital, Monza, Italy. 2. Medical Genetics Laboratory, ASST Papa Giovanni XXIII, Bergamo, Italy. 3. Referral Center for Cardiomyopathies, Careggi University Hospital, Florence, Italy. 4. Cardiology, Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum-University of Bologna, Sant'Orsola-Malpighi Polyclinic, Bologna, Italy. 5. Anatomy and Histopathology Laboratory, Monza Hospital, Monza, Italy. 6. Nephrology and Dialysis Unit, San Gerardo Hospital, Monza, Italy. 7. Cardiomyopathy Center, Monza Hospital, Bucharest, Romania.
Abstract
Importance: Diagnostic screening for Anderson-Fabry cardiomyopathy (AFC) is performed in the presence of specific clinical red flags in patients with hypertrophic cardiomyopathy (HCM) older than 25 years. However, left ventricular outflow tract obstruction (LVOTO) has been traditionally considered an exclusion criteria for AFC. Objective: To examine a series of patients diagnosed with HCM and severe basal LVOTO undergoing myectomy in whom the diagnosis of AFC was suspected by the cardiac surgeon intraoperatively and confirmed by histological and genetic examinations. Design, Setting, and Participants: This retrospective analysis of patients undergoing surgical septal reduction strategies was conducted in 3 European tertiary referral centers for HCM from July 2013 to December 2016. Patients with a clinical diagnosis of obstructive HCM referred for surgical management of LVOTO were observed for at least 18 months after the procedure (mean [SD] follow-up, 33 [14] months). Main Outcomes and Measures: Etiology of patients with HCM who underwent surgical myectomy. Results: From 2013, 235 consecutive patients with a clinical diagnosis of HCM underwent septal myectomy. The cardiac surgeon suspected a storage disease in 3 patients (1.3%) while inspecting their heart samples extracted from myectomy. The mean (SD) age at diagnosis for these 3 patients was 42 (4) years; all were male. None of the 3 patients presented with extracardiac features suggestive of AFC. All patients showed asymmetrical left ventricular hypertrophy, with maximal left ventricular thickness in the basal septum (19-31 mm), severe basal LVOTO (70-120 mm Hg), and left atrial dilatation (44-57 mm). Only 1 patient presented with late gadolinium enhancement on cardiovascular magnetic resonance at the right ventricle insertion site. The mean (SD) age at surgical procedure was 63 (5) years. On tactile sensation, the surgeon felt a spongy consistency of the surgical samples, different from the usual stony-elastic consistency typical of classic HCM, and this prompted histological examinations. Histology showed evidence of intracellular storage, and genetic analysis confirmed a GLA A gene mutation (p.Asn215Ser) in all 3 patients. Conclusions and Relevance: Screening for AFC should be performed even in the absence of red flags in patients with HCM older than 25 years.
Importance: Diagnostic screening for Anderson-Fabry cardiomyopathy (AFC) is performed in the presence of specific clinical red flags in patients with hypertrophic cardiomyopathy (HCM) older than 25 years. However, left ventricular outflow tract obstruction (LVOTO) has been traditionally considered an exclusion criteria for AFC. Objective: To examine a series of patients diagnosed with HCM and severe basal LVOTO undergoing myectomy in whom the diagnosis of AFC was suspected by the cardiac surgeon intraoperatively and confirmed by histological and genetic examinations. Design, Setting, and Participants: This retrospective analysis of patients undergoing surgical septal reduction strategies was conducted in 3 European tertiary referral centers for HCM from July 2013 to December 2016. Patients with a clinical diagnosis of obstructive HCM referred for surgical management of LVOTO were observed for at least 18 months after the procedure (mean [SD] follow-up, 33 [14] months). Main Outcomes and Measures: Etiology of patients with HCM who underwent surgical myectomy. Results: From 2013, 235 consecutive patients with a clinical diagnosis of HCM underwent septal myectomy. The cardiac surgeon suspected a storage disease in 3 patients (1.3%) while inspecting their heart samples extracted from myectomy. The mean (SD) age at diagnosis for these 3 patients was 42 (4) years; all were male. None of the 3 patients presented with extracardiac features suggestive of AFC. All patients showed asymmetrical left ventricular hypertrophy, with maximal left ventricular thickness in the basal septum (19-31 mm), severe basal LVOTO (70-120 mm Hg), and left atrial dilatation (44-57 mm). Only 1 patient presented with late gadolinium enhancement on cardiovascular magnetic resonance at the right ventricle insertion site. The mean (SD) age at surgical procedure was 63 (5) years. On tactile sensation, the surgeon felt a spongy consistency of the surgical samples, different from the usual stony-elastic consistency typical of classic HCM, and this prompted histological examinations. Histology showed evidence of intracellular storage, and genetic analysis confirmed a GLA A gene mutation (p.Asn215Ser) in all 3 patients. Conclusions and Relevance: Screening for AFC should be performed even in the absence of red flags in patients with HCM older than 25 years.
Authors: B E Smid; L van der Tol; F Cecchi; P M Elliott; D A Hughes; G E Linthorst; J Timmermans; F Weidemann; M L West; M Biegstraaten; R H Lekanne Deprez; S Florquin; P G Postema; B Tomberli; A C van der Wal; M A van den Bergh Weerman; C E Hollak Journal: Int J Cardiol Date: 2014-09-20 Impact factor: 4.164
Authors: Perry Elliott; Robert Baker; Ferdinando Pasquale; Giovanni Quarta; Hatim Ebrahim; Atul B Mehta; Derralynn A Hughes Journal: Heart Date: 2011-09-02 Impact factor: 5.994
Authors: Ales Linhart; Christoph Kampmann; José L Zamorano; Gere Sunder-Plassmann; Michael Beck; Atul Mehta; Perry M Elliott Journal: Eur Heart J Date: 2007-05-05 Impact factor: 29.983
Authors: Claudio Rapezzi; Eloisa Arbustini; Alida L P Caforio; Philippe Charron; Juan Gimeno-Blanes; Tiina Heliö; Ales Linhart; Jens Mogensen; Yigal Pinto; Arsen Ristic; Hubert Seggewiss; Gianfranco Sinagra; Luigi Tavazzi; Perry M Elliott Journal: Eur Heart J Date: 2012-12-04 Impact factor: 29.983
Authors: Paolo Ferrazzi; Paolo Spirito; Attilio Iacovoni; Alice Calabrese; Katrin Migliorati; Caterina Simon; Samuele Pentiricci; Daniele Poggio; Massimiliano Grillo; Pietro Amigoni; Maria Iascone; Andrea Mortara; Barry J Maron; Michele Senni; Paolo Bruzzi Journal: J Am Coll Cardiol Date: 2015-10-13 Impact factor: 24.094
Authors: Attilio Iacovoni; Paolo Spirito; Caterina Simon; Maria Iascone; Giovanni Di Dedda; Paolo De Filippo; Samuele Pentiricci; Luca Boni; Michele Senni; Antonello Gavazzi; Paolo Ferrazzi Journal: Eur Heart J Date: 2012-04-20 Impact factor: 29.983
Authors: Yiting Fan; Tsz-Ngai Chan; Josie T Y Chow; Kevin K H Kam; Wai-Kin Chi; Joseph Y S Chan; Erik Fung; Mabel M P Tong; Jeffery K T Wong; Paul C L Choi; David K H Chan; Bun Sheng; Alex Pui-Wai Lee Journal: J Clin Med Date: 2021-05-17 Impact factor: 4.241